Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients

ABSTRACT: We investigated a panel of 21 genes by parallel sequencing on the Ion Torrent Personal Genome Machine platform. We sequenced 65 CRCs that were treated with cetuximab or panitumumab ( 37 samples were responsive and 28 were resistant).

INSTRUMENT(S): Ion Torrent PGM

ORGANISM(S): Homo sapiens

SUBMITTER: Cristian Bassi 

PROVIDER: E-MTAB-3883 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress